SCHEMBL1356508

SCHEMBL1356508

CC(NCc1ccco1)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.54
TP53 P04637 2/20 0.54
KDM4E B2RXH2 1/20 0.54
POLB P06746 3/20 0.50
HPGD P15428 2/20 0.50
ATM Q13315 1/20 0.49
TDP1 Q9NUW8 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
APEX1 P27695 1/20 0.48
CTDSP1 Q9GZU7 1/20 0.48
KMT2A Q03164 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MAPT P10636 2/20 0.48
MEN1 O00255 1/20 0.48
RAB9A P51151 1/20 0.48
GAA P10253 1/20 0.48
NR4A2 P43354 1/20 0.48
HSD17B10 Q99714 1/20 0.48
EPHX2 P34913 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1356510 1.00 ALDH1A1 (0.54) ALDH1A1TP53KDM4EPOLBHPGD
SCHEMBL6853606 0.81 ALDH1A1 (0.56) ALDH1A1TP53KDM4EPOLBHPGD
SCHEMBL10917121 0.81 ALDH1A1 (0.56) ALDH1A1TP53KDM4EPOLBHPGD
SCHEMBL6905360 0.81 ALDH1A1 (0.51) ALDH1A1TP53KDM4EPOLBHPGD
SCHEMBL6905358 0.81 ALDH1A1 (0.51) ALDH1A1TP53KDM4EPOLBHPGD
SCHEMBL8795665 0.79 ALDH1A1 (0.49) ALDH1A1TP53KDM4EPOLBHPGD
SCHEMBL4677601 0.78 TDP1 (0.50) ALDH1A1POLBHPGDATMTDP1
SCHEMBL105281 0.78 MAPT (0.51) ALDH1A1TP53KDM4EPOLBHPGD
SCHEMBL6945061 0.78 L3MBTL1 (0.62) ALDH1A1KDM4EPOLBHPGDTDP1
SCHEMBL12172822 0.78 HPGD (0.56) ALDH1A1TP53POLBHPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130012685-A1 NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR AFFYMAX, INC. (US) 2013-01-10 US disclosed
US-20120157660-A1 NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR AFFYMAX, INC. (US) 2012-06-21 US disclosed
US-20110282029-A1 NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR AFFYMAX, INC. (US) 2011-11-17 US disclosed
US-20090005292-A1 Novel Peptides that Bind to the Erythropoietin Receptor AFFYMAX, INC. (US) 2009-01-01 US disclosed
US-20080108564-A1 NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR AFFYMAX, INC. (US) 2008-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130012685-A1 NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR EPOR, PROKR1, EDNRB ALDH1A1 4119/4885TP53 2568/4885KDM4E 4304/4885
US-20080108564-A1 NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR EPOR, PROKR1, EDNRB ALDH1A1 4119/4885TP53 2568/4885KDM4E 4304/4885
US-20110282029-A1 NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR EPOR, PROKR1, EDNRB ALDH1A1 4119/4885TP53 2568/4885KDM4E 4304/4885
US-20090005292-A1 Novel Peptides that Bind to the Erythropoietin Receptor EPOR, PROKR1, EDNRB ALDH1A1 4119/4885TP53 2568/4885KDM4E 4304/4885
US-20120157660-A1 NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR EPOR, PROKR1, EDNRB ALDH1A1 4119/4885TP53 2568/4885KDM4E 4304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.